Literature DB >> 32790856

Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome.

Won Sok Lee1, Elizabeth Margolskee1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32790856      PMCID: PMC7426643          DOI: 10.1182/blood.2020007132

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
A 7-year-old girl with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure presented with 4 days of fever, nausea, vomiting, diarrhea, and dark urine. At presentation, she was febrile (39.7°C), tachycardic, and tachypneic with normal blood pressure. Conjunctivitis, oropharyngeal erythema, cracked lips, and a distended abdomen were noted. Polymerase chain reaction testing for SARS-CoV-2 was positive. Laboratory testing showed elevated inflammatory markers, liver enzymes, and D-dimer. Two days after admission, her complete blood count revealed the following: white blood cell count, 63.1 × 109/L; hemoglobin, 6.9 g/dL (with a normal mean corpuscular volume); and platelets, 370 × 109/L. A peripheral blood smear showed 55% neutrophils, 9% bands, 8% metamyelocytes, 5% myelocytes, 13% monocytes, and 10% lymphocytes (panel A; original magnification ×600, Wright-Giemsa stain). There were also plasmacytoid lymphocytes (panel B; original magnification ×600, Wright-Giemsa stain), anisocytosis, and 7% nucleated red blood cells (panel C; original magnification ×600, Wright-Giemsa stain). The patient received 1 mg/kg prednisone and 81 mg of aspirin daily and changes resolved in 4 days. Multisystem inflammatory syndrome in children (MIS-C) is a rare, newly reported manifestation of infection with SARS-CoV-2 that shares features with Kawasaki disease. Although plasmacytoid lymphocytes are frequently seen in critically ill COVID-19+ children, leukoerythroblastosis is unusual (institutional experience). One case report describes this finding in a COVID-19+ adult with respiratory failure, but little is known about the hematologic manifestations of MIS-C (A. Mitra, D. M. Dwyre, M. Schivo, et al, Am J Hematol. doi:10.1002/ajh.25793). Interestingly, leukoerythroblastosis can occur in children with Kawasaki disease. These findings help broaden awareness of the spectrum of SARS-CoV-2 infection in children.
  4 in total

1.  Leukoerythroblastosis - An unsusal presentation of COVID 19 infection.

Authors:  Shareh Naqvi; Namrata P Awasthi; Pravin K Das; Nuzhat Husain
Journal:  Clin Epidemiol Glob Health       Date:  2022-03-18

2.  Leukoerythroblastosis in a Sickle Cell Patient With Pregnancy: An Interesting Peripheral Blood Smear Finding.

Authors:  Anupam Mitra; Ananya Datta Mitra; Gopal Patel; Denis M Dwyre; John P Graff
Journal:  J Hematol       Date:  2021-12-13

Review 3.  Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes.

Authors:  Mônica O Santos; Lucas C Gonçalves; Paulo A N Silva; André L E Moreira; Célia R M Ito; Fernanda A O Peixoto; Isabela J Wastowski; Lilian C Carneiro; Melissa A G Avelino
Journal:  J Pediatr (Rio J)       Date:  2021-12-03       Impact factor: 2.990

4.  Leukoerythroblastic reaction associated with COVID-19 infection. Case report

Authors:  Martin Milanesio; David Francisco Suasnabar; Alejandro Giaj-Merlera; Rocío Gabriela Cebreros; Federico Ariel Marucco
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2021-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.